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Objectives: The objective of this study was to determine the frequency of omitted doses of antibacterial agents
and explore a number of risk factors, including the effect of a restricted antibacterial system.
Methods: Antibacterial datawere extracted from a hospital electronic prescribing andmedication administration
system for the period 1 January to 30 April 2014. Percentage dose omission rateswere calculated. Omission rates
for the first dose of antibacterial courses were analysed using logistic regression to identify any correlation
between first dose omission rates and potential risk factors, including the antibacterials’ restriction status and
whether or not they were ward stock.
Results: The study included 90761 antibacterial doses. Of these, 6535 (7.2%) were documented as having been
omitted; omission of 847 (0.9% of 90761) was due to medication being unavailable. Non-restricted, ward stock
antibacterials had the lowest frequency of omission, with 6.2% (271 of 4391) first doses omitted. The prevalence
was 10.4% (27 of 260) for restricted, ward-stock antibacterials (OR¼1.6, 95% CI¼1.0–2.4, P¼0.027) and 15.5%
(53 of 341) for non-restricted, non-ward stock antibacterials (OR¼2.7, 95% CI¼2.0–3.7, P,0.001). Restricted,
non-ward stock antibacterials had the highest frequency (30.7%, 71 of 231; OR¼6.2, 95% CI¼4.5–8.4, P,0.001).
Conclusions: Antibacterials not stocked in clinical areas were significantlymore likely to be omitted. The prevalence
of omitted doses increased further if the antibiotic was also restricted. To achieve safe, effective antimicrobial use, a
balance is needed between promoting antimicrobial stewardship and preventing unintended omitted doses.
Introduction
It is widely recognized that many advances in modern medicine
have been made possible by the availability of effective antibac-
terials. However, antibacterial resistance is a growing worldwide
public health issue and a significant public health concern in the
UK1 and elsewhere.2
Clostridium difficile-associated diarrhoea is often associated
with antibacterial prescribing and deemed largely avoidable;3–6
it increases mortality and morbidity, hospital length of stay and
healthcare costs.7,8 It is imperative that available antibacterials
are conserved and utilized in a way that treats infections effect-
ively but at the same time reduces the risk of C. difficile-associated
diarrhoea and antibacterial resistance. The term ‘antimicrobial
stewardship’ captures these desired practices and outcomes.9
A Cochrane review of antimicrobial stewardship interventions to
improve inpatient antibacterial prescribing practices concluded
that restrictive interventions work faster than persuasive interven-
tions in bringing about a change in antibacterial prescribing prac-
tice. However, the review goes on to suggest more reassurance is
needed that restrictive interventions do not have unintended con-
sequences.9 The effect of such restriction systems on omitted
antibacterial doses has not been studied. Omitted or delayed
doses have the potential for patient harm10 through (i) increased
risk of treatment failure, thus hampering the goals of the Surviving
Sepsis Campaign,11 and (ii) selection for more resistant strains of
bacteria.12
In response to escalating C. difficile rates, the study hospital
introduced a more robust, restricted antibacterial system for
adult inpatients in May 2013.
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The objectives of the present study were to determine the fre-
quency of omitted doses of antibacterial agents and to explore a
number of risk factors for omitted doses. The primary risk factors
of interest were whether antibacterials were classified as
restricted and/or removed from ward stock; we also explored
the time doses were scheduled to be administered, day of the
week, route of administration and clinical specialty.
Methods
Setting
The study was conducted at a 650 bed teaching hospital in England. The
hospital used a typical UK drug distribution system in which commonly
used medications were kept in clinical areas as ward stock; non-stock
medications were dispensed to individual patients from the pharmacy
department. However, unlike most English hospitals,13 an electronic pre-
scribing and medication administration (EPMA; JAC Computer Services
Ltd) system was in use in all inpatient areas except for the emergency
department and critical care unit.
Following the introduction of the restriction policy in May 2013, individ-
ual antibacterial agents were classified by the antibacterial committee as
either restricted or non-restricted. The restricted antibacterials were only
to be prescribed for pre-authorized indications as listed in local antimicro-
bial guidelines, or following discussion with a consultant microbiologist.
Such approval was evidenced bydocumentation of a unique alphanumeric
code issued by the consultant microbiologist and documented on the
medication order.
Restricted antibacterials that appeared in the antibacterial guidelines
for common infections were stocked on wards where these infections
were commonly treated.
Data collection
Data on individual adult inpatient doses of prescribed antibacterials (as
defined by British National Formulary 66 Section 5.1)14 were extracted
from the EPMA system relating to a 4 month period between 1 January
and 30 April 2014. Paediatric wards, critical care and the emergency
department were excluded. Data were extracted using a bespoke Crystal
Report (Crystal Reporting Application; SAP England 2014) and exported to
Excel (Microsoft Office 2010).
The following data were extracted for each prescribed dose: ward
name; a unique patient identifier; drug name; form; strength; route of
administration; scheduled date and time; administered date and time;
administration status (administered or omitted); the reason given for
any non-administration (as selected by the administering nurse from a
drop-downmenu); whether or not the dose was the first dose of that anti-
bacterial course; whether or not the antibacterial prescribed was ward
stock; and whether or not the antibacterial was categorized as restricted.
Data analysis
Regularly prescribed and ‘stat’ (once only) doses were included in the ana-
lysis. Doseswere removed from the dataset if an intentional dose omission
was evident (Table 1). Doses documented as being omitted for the remain-
ing reasons (Table 1) were assumed to represent doses intended to be
given and therefore included in analysis.
The overall prevalence of omitted doses was calculated together with
the prevalence of doses documented specifically as being omitted due to
unavailability. Multivariable binary logistic regression analysis was per-
formed using SPSS (version 21; IBM 2012) to explore the impact of poten-
tial risk factors on the likelihood of the first dose of each antibacterial
course being omitted. To meet the independence assumption of logistic
regression, for patients prescribed more than one course of antibacterials
in the same patient episode we randomly selected one of these for ana-
lysis. We calculated ORs and their CIs for the risk of an omitted first dose.
Our primary analysis focused on restriction and ward-stock status; as
these were not independent of each other, each drug was classified as:
(i) not restricted and ward stock; (ii) restricted and ward stock; (iii) non-
ward stock and not restricted; or (iv) non-ward stock and restricted. The
model included the following categorical independent variables: (i) or (ii)
or (iii) or (iv); weekday or weekend; scheduled in or outside standard work-
ing hours; clinical specialty (medicine, surgery and theatres, obstetrics and
gynaecology, or oncology); and route of administration (intravenous, oral
or other). The dependent variable was first dose omitted versus not
omitted.
Ethics approval was not required as this study was deemed a service
evaluation; no patient-identifiable data were extracted.
Results
Over the 4 month study period, 90761 antibacterial doses were
extracted from the EPMA system and included in the analysis.
Of these, 7.2% (6535 of 90761) were documented as having
been omitted, and omission of 0.9% (847 of 90761) was due to
medication being unavailable (Table 1).
Logistic regression analysis indicated that first doses of non-
restricted, ward-stock antibacterials had the lowest risk of being
omitted (271 of 4391 first doses; 6.2%; Table 2). The ORs for an
omitted first dose in the other categories were 1.6 (95%
CI¼1.0–2.4, P¼0.027) for restricted, ward-stock antibacterials,
2.7 (95% CI¼2.0–3.7, P,0.001) for non-restricted, non-stock
antibacterials and 6.2 (95% CI¼4.5–8.4, P,0.001) for restricted,
non-ward-stock antibacterials. Day of the week, route of adminis-
tration and clinical specialty were non-significant (P.0.05) and
removed from the model. Antibacterials scheduled to be
Table 1. Reasons documented for the antibacterial doses omitted;
percentages shown are percentages of intended doses that were
documented as having been omitted due to the reason stated
Reason given for omitted dose
All antibacterial doses,
n¼90761
Administration unknown 1085 (1.2%)
Contra-indicated due to patient factors 1077 (1.2%)
Deferred administration 1 (,0.1%)
Drug awaiting medical review 1172 (1.3%)
Medication unavailable 847 (0.9%)
Other reason 608 (0.7%)
Patient asleep 77 (0.1%)
Patient declined dose 566 (0.6%)
Nil by mouth 226 (0.2%)
Route unavailable 679 (0.7%)
Allergy 6 (,0.1%)
Xxxx 191 (0.2%)
Total missed doses 6535 (7.2%)
The following reasons for an omitted dose were taken to be intentional
and removed from the dataset: ‘alternative route used’; ‘alternative
administered’; ‘drug discontinued’; ‘not charted prior to discharge’; ‘order
suspended’; ‘patient absent’; ‘patient on short-term leave’; ‘transferred
patient’; ‘administration lapsed’; ‘administration discontinued’; ‘zero mg
dose prescribed’; and ‘not required in recovery’.
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administered within standard working hours had a lower fre-
quency of omitted first doses (149 of 2577; 5.8%) compared
with those scheduled outside standard working hours (273 of
2646; 10.3%) (OR¼1.7, 95% CI¼1.3–2.0, P,0.001; Table 2).
The antibacterials more commonly associated with omitted
doses due to medication unavailability were: nitrofurantoin
tablets (100 of 847 doses documented as being omitted due to
unavailability), which were not restricted but not widely stocked
in ward areas; and ciprofloxacin (84 of 847) and levofloxacin
tablets (44 of 847), both of which were restricted and not widely
stocked in ward areas.
Discussion
Key findings
Of 90761 antibacterial doses prescribed for adult inpatients, 6535
(7.2%) were omitted. We found that 0.9% of all doses were docu-
mented as having been omitted due to medication unavailability,
a potentially avoidable reason and therefore a particular cause for
concern. We found that the non-stock antibacterials were signifi-
cantly more likely to be omitted than those that were ward stock.
If those non-stock antibacterials were also restricted the risk of an
omitted dose increased further. Being restricted also increased
the risk of omission for ward-stock antibacterials, which may be
because stock holding is intentionally low to prompt pharmacy
review before further supplies are made. These data suggest
that a restricted antibacterial system may have an unintended
negative consequence in contributing to dose omissions.
Antibacterial doses scheduled outside normal standard working
hours were also more likely to be omitted than those scheduled
during standard working hours.
Interpretation and implications
If we removed the restriction system and ensured all antibacter-
ials were adequately stocked in ward areas, then we could
expect the frequency of omitted first doses to reduce from the
current rate of 8.1% to 6.2% of intended first doses. Likewise,
doses documented as being omitted due to medication being
unavailable might be expected to decrease from 1.9% of first
doses to 0.3%.
We have also identified antibacterials commonly associated
with omitted doses. Modifications to ward-stock holdings can
now be considered to reduce the risks associated with omitted
doses while retaining the benefits of a restricted system.
Comparison with previous literature
This study confirms previous research into the frequency and rea-
sons for omitted antibacterial doses. Carruthers et al.15 set out to
determine a minimal acceptable range for omitted antibacterial
doses and suggested an acceptable level to be 5% of the total
number of intended doses. In their 1 year study of 1157576 anti-
bacterial doses prescribed using EPMA, the frequency of missed
doses ranged from 5.90% to 10.26% across three UK hospital
organizations. The frequency of missed doses due to medication
being unavailable ranged from 0.64% to 0.98% across the three
organizations. Our study identified similar findings of 7.2% of all
doses omitted, with 0.9% omitted due to unavailability.
Strengths and limitations
We were able to analyse a large sample across a whole organiza-
tion, drawing on one of the benefits of EPMA in allowing large data-
sets for secondaryanalysis.With the exception of Carruthers et al.,15
previous studies of medication omissions have been based on
either point prevalence methods16 or direct observation of medi-
cation administration,17 both of which are more labour intensive
and thus provide smaller sample sizes.18 Both the Hawthorne
effect and observer bias are further potential limitations of direct
observation, a limitation avoided through analysing electronic
datasets.
Table 2. Logistic regression model output and percentage of omitted doses due to any reason and the percentage of omitted doses due to medication
unavailability in the sampled first dose data in the antibacterial groups
Antibacterial group
Number of
intended
first doses
Number of first
doses omitted for
any reason (% of
intended doses)
Number of first doses
omitted due to medication
unavailability (% of
intended doses)
OR, omitted
doses for any
reason
(95% CI)
P value, doses
omitted for any
reason
All sampled first antibacterial doses 5223 423 (8.1) 102 (1.9)
Not restricted and ward stock 4391 271 (6.2) 13 (0.3) control
Restricted and ward stock 260 27 (10.4) 6 (2.3) 1.6 (1.0–2.4) 0.027
Not restricted and not ward stock 341 53 (15.5) 30 (8.8) 2.7 (2.0–3.7) ,0.001
Restricted and not ward stock 231 71 (30.7) 53 (22.9) 6.2 (4.5–8.4) ,0.001
In standard working hours
(0830–1700)
2577 149 (5.8) 27 (1.0) control
Outside standard working hours
(1701–0829)
2646 273 (10.3) 73 (2.8) 1.7 (1.3–2.0) ,0.001
Logistic regression model: x2¼167.653, d.f.¼4, P,0.001; Cox and Snell R2¼0.032; Nagelkerke R2¼0.074; Hosmer and Lemeshow test, P.0.05.
Interaction between ward stock/restriction status and in/outside standard working hours was not significant (P¼0.315) and the interaction was
removed from the model.
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Although the EPMA system in the study hospital mandated a
reason to be documented for any omitted dose, therewere limita-
tions in this regard. First, there were two options for recording rea-
sons for omitted doses that resulted in incomplete data: ‘xxxx’
and ‘administration unknown’. Of the 90761 intended antibacter-
ial doses, 1.2% were documented as ‘administration unknown’
and a further 0.2% as ‘xxxx’. These limitations may conceal the
true nature of omitted doses. Second, the reasons selected
from the drop-down menu may not accurately reflect the actual
reason for the omitted dose.
The study was observational and can therefore identify corre-
lations but not causality. The EPMA systemwas not fully deployed
in the study hospital prior to the implementation of the restricted
antibacterial system.We were therefore unable to obtain omitted
dose data prior to the introduction of the restricted antibacterial
system for comparison. A further limitation was the exclusion of
Critical Care and the Emergency Department, where patients
may be more likely to be affected by omitted doses, as well as
the paediatric wards.
Implications for future research
Kumar et al.19 previously studied the consequences of delayed
antibacterial doses in patients with septic shock and found it to
have a negative impact on survival in these patients. Our study
does not distinguish between those patients with septic shock
and those with less severe infections. We do not know whether
any doses omitted as a consequence of the restricted policy
increased morbidity or mortality and further work is needed to
determine whether restricted policies have any detrimental effect
on patient outcomes.
One of the aims of the restricted policy studied was to
reduce rates of C. difficile-associated diarrhoea. Rates of C. difficile-
associated diarrhoea at the study hospital are at their lowest levels
since mandatory recording began in 2007 but the reasons for this
may be multifactorial and not due solely to the restricted policy.
The effect of the studied restricted policy on resistance of key
bacteria to key antibacterials has not been determined.
Conclusions
Doses of non-stock antibacterials were more likely to be omitted
than those that were stock; stock status was the single most
important risk factor for an omitted first dose. The likelihood of
an omitted dose was increased further if the antibacterial was
restricted. Doses scheduled at a time outside standard working
hours were more likely to be omitted when compared with
doses scheduled within standard working hours. This study
demonstrates the potential for restricted antibacterial policies
to increase the prevalence of omitted antibacterial doses. When
developing a restriction system, a balance is needed in terms of
facilitating antimicrobial stewardship versus ensuring patients
receive the doses needed.
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